30/10/2024: Prof. Nicoletta Colombo, member of the MaNGO Scientific Committee, has completed her two-year term as Chair of ENGOT (European Network for Gynaecological Oncological Trial groups) for the period 2022-2024. Dr Elena Biagioli (MaNGO), is the Operational Chair of ENGOT for the period 2024-2026.

20/10/2024:  Dr. Annamaria Ferrero, member of the MaNGO's Scientific Committee, together with Dr. Alexandra Leary, will lead the webinar organised by ESGO (European Society of Gynaecological Cancer) "Debates in endometrial cancer management: how to choose 1st line therapy for your metastatic EC patient". The webinar will be held on 29 November 2024, 2.00 pm CET, you can register on the ESGO website → Webinar information and registration link

16/09/2024. The IRCCS San Gerardo dei Tintori Foundation of Monza, already internationally accredited by the European Society of Gynaecological Oncology (ESGO) as a Reference centre for Ovarian Cancer, has also obtained the prestigious recognition as a Reference centre for Endometrial Cancer. → read the news

12/09/2024. Conclusions of the first GCIG Endometrial Cancer Consensus Conference published in The Lancet Oncology: "Clinical research in endometrial cancer: consensus recommendations from the Gynecologic Cancer InterGroup". The Gynecologic Cancer InterGroup (GCIG) brings together 33 cooperative groups from around the world involved in clinical research in the onco-gynaecological field. The consensus was held in Korea in November 2023 and was attended by Prof. Nicoletta Colombo and Prof. Paolo Zola as a delegates of the MaNGO group. → Lancet article  |  → Appendix

06/12/2023. Research developments towards the early diagnosis of ovarian cancer, article published on SCIENCE Translational Medicine.  → Read the article

01/10/2023. ESGO Lifetime Achievement Award 2023 to Professor Nicoletta Colombo, MaNGO Scientific Commitee member and Director of Gynecologic Program of European Institute of Oncology (IEO). → read the news

17/01/2023. The Ginecology department of Ospedale Del Ponte di Varese is awarded by ESGO as the first center of excellence in Europe for uterine cancer treatment and is accredited as ESGO center for training in Gynaecological Oncology and advanced Cancer surgery → read the news